Dr. Shi focuses on investing in diagnostics and medical devices in China as General Partner of Serica Partners. Among Serica’s portfolio, he serves as CEO of Nuprobe and Vice Chairman of Anchor Dx. Previously he was Founding President Asia Pacific of QIAGEN and held senior positions at Aura Partners, Bridge Pharmaceuticals, Genospectra, and A. M. Pappas & Associates. He was also a faculty member at the National University of Singapore, School of Medicine and a cancer research scientist at Merck & Co.

Victor is Chairman of Bayhelix Group, a global association of Chinese life science business executives, Deputy Secretary-General of Chinese In-Vitro Diagnostics Industry Association, Vice Chairman of the Advanced Medical Technology Association (AdvaMed) China board, and serves on the Hong Kong Stock Exchange Biotech Advisory Committee.